Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Net-Borrowings" stands at 9.07 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
Johnson & Johnson's third quarter result of -5.14 Billion USD for the item "Net Borrowings" represents a decrease of -116.46 percent compared to it's second quarter result.
Also, Johnson & Johnson's third quarter result of -5.14 Billion USD for the item "Net Borrowings" represents an increase of 20.03 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 9.07 Billion USD for the item "Net Borrowings" represents an increase of 16.56 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 18.12 Billion United States Dollars compared to the value the year prior.
The 1 year change is 18.12 Billion United States Dollars.
The 3 year change is 7.92 Billion United States Dollars.
The 5 year change is 1.11 Billion United States Dollars.
The 10 year change is 4.21 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Borrowings | 905,699,262,464.00 |
![]() | AbbVie Inc - Net Borrowings | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Borrowings | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Borrowings | 280,205,508,085.11 |
![]() | Novartis AG - Net Borrowings | 255,096,620,580.91 |